Showing results (931-940 of 3,473) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|March 1, 1977
Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantationI Odar-CederlofClinical Pharmacokinetics|June 1, 1988
Pharmacokinetics and blood pressure effects of felodipine in elderly hypertensive patients. A comparison with young healthy subjectsS Landahl, B Edgar, M Gabrielsson, et al.Clinical Pharmacokinetics|June 7, 2020
Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and CimetidineSabrina T Wiebe, Thomas Giessmann, Kathrin Hohl, et al.Clinical Pharmacokinetics|January 1, 1977
Clinical pharmacokinetics of digoxin in infantsG Wettrell, K E AnderssonClinical Pharmacokinetics|September 1, 1978
Clinical pharmacokinetics of chlordiazepoxideD J Greenblatt, R I Shader, S M MacLeod, et al.Clinical Pharmacokinetics|September 13, 2021
Age-Related Change in Hepatic Clearance Inferred from Multiple Population Pharmacokinetic Studies: Comparison with Renal Clearance and Their Associations with Organ Weight and Blood FlowKuretake Soejima, Hiromi Sato, Akihiro HisakaClinical Pharmacokinetics|March 1, 1981
Quality control of drug assaysG Ayers, D Burnett, A Griffiths, et al.Clinical Pharmacokinetics|September 1, 1978
Pharmacokinetics of lorcainide in man: a new antiarrhythmic agentU Klotz, P Müller-Seydlitz, P HeimburgClinical Pharmacokinetics|July 16, 2016
Discrepancies between the Cockcroft-Gault and Chronic Kidney Disease Epidemiology (CKD-EPI) Equations: Implications for Refining Drug Dosage Adjustment StrategiesPierre Delanaye, Fabrice Guerber, André Scheen, et al.Clinical Pharmacokinetics|December 1, 1989
Effects of age on the elimination of labetalolM L Rocci, T Valiquett, M A SirgoPageof 348